Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Purcell LA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Purcell Lalonde, Magali
Il s'agit d'une hypothèse largement répandue que l’égo-dystonie et l’égo-syntonie caractérisent les obsessions dans les troubles des conduites alimentaires (TCA) et que ces facteurs sont cliniquement pertinents pour la conceptualisation et l
Externí odkaz:
http://hdl.handle.net/1866/11662
Autor:
Rosen LE; Vir Biotechnology, San Francisco, CA 94158, USA., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., De Marco A; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Pinto D; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Foreman WB; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA., Taylor AL; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA., Bohan D; Vir Biotechnology, San Francisco, CA 94158, USA., Rietz T; Vir Biotechnology, San Francisco, CA 94158, USA., Errico JM; Vir Biotechnology, San Francisco, CA 94158, USA., Hauser K; Vir Biotechnology, San Francisco, CA 94158, USA., Dang HV; Vir Biotechnology, San Francisco, CA 94158, USA., Chartron JW; ProtaBody, Pasadena, CA 91105, USA., Giurdanella M; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Cusumano G; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Saliba C; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Zatta F; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Addetia A; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Zepeda SK; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Brown J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Lee J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Dellota E Jr; Vir Biotechnology, San Francisco, CA 94158, USA., Rajesh A; Vir Biotechnology, San Francisco, CA 94158, USA., Noack J; Vir Biotechnology, San Francisco, CA 94158, USA., Tao Q; Vir Biotechnology, San Francisco, CA 94158, USA., DaCosta Y; Vir Biotechnology, San Francisco, CA 94158, USA., Tsu B; Vir Biotechnology, San Francisco, CA 94158, USA., Acosta R; Vir Biotechnology, San Francisco, CA 94158, USA., Subramanian S; Vir Biotechnology, San Francisco, CA 94158, USA., de Melo GD; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, F-75015 Paris, France., Kergoat L; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, F-75015 Paris, France., Zhang I; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Liu Z; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA., Guarino B; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Schmid MA; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Schnell G; Vir Biotechnology, San Francisco, CA 94158, USA., Miller JL; Vir Biotechnology, San Francisco, CA 94158, USA., Lempp FA; Vir Biotechnology, San Francisco, CA 94158, USA; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Czudnochowski N; Vir Biotechnology, San Francisco, CA 94158, USA., Cameroni E; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Whelan SPJ; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA., Bourhy H; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, F-75015 Paris, France., Purcell LA; Vir Biotechnology, San Francisco, CA 94158, USA., Benigni F; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., di Iulio J; Vir Biotechnology, San Francisco, CA 94158, USA., Pizzuto MS; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Lanzavecchia A; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Telenti A; Vir Biotechnology, San Francisco, CA 94158, USA., Snell G; Vir Biotechnology, San Francisco, CA 94158, USA., Corti D; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: dcorti@vir.bio., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu., Starr TN; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: tyler.starr@biochem.utah.edu.
Publikováno v:
Cell [Cell] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Lempp FA; Vir Biotechnology, San Francisco, California 94158, USA. Electronic address: flempp@vir.bio., Volz T; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems and Heidelberg Sites, Germany., Cameroni E; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Benigni F; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Zhou J; Vir Biotechnology, San Francisco, California 94158, USA., Rosen LE; Vir Biotechnology, San Francisco, California 94158, USA., Noack J; Vir Biotechnology, San Francisco, California 94158, USA., Zatta F; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Kaiser H; Vir Biotechnology, San Francisco, California 94158, USA., Bianchi S; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Lombardo G; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Jaconi S; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Vincenzetti L; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Imam H; Vir Biotechnology, San Francisco, California 94158, USA., Soriaga LB; Vir Biotechnology, San Francisco, California 94158, USA., Passini N; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Belnap DM; School of Biological Sciences and Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, USA., Schulze A; Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Lütgehetmann M; German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems and Heidelberg Sites, Germany; Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany., Telenti A; Vir Biotechnology, San Francisco, California 94158, USA., Cathcart AL; Vir Biotechnology, San Francisco, California 94158, USA., Snell G; Vir Biotechnology, San Francisco, California 94158, USA., Purcell LA; Vir Biotechnology, San Francisco, California 94158, USA., Hebner CM; Vir Biotechnology, San Francisco, California 94158, USA., Urban S; German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems and Heidelberg Sites, Germany; Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Dandri M; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems and Heidelberg Sites, Germany., Corti D; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Schmid MA; Humabs Biomed SA, A Subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: mschmid@vir.bio.
Publikováno v:
Journal of hepatology [J Hepatol] 2023 Nov; Vol. 79 (5), pp. 1129-1138. Date of Electronic Publication: 2023 Jul 17.
Autor:
Addetia A; Department of Biochemistry, University of Washington, Seattle, WA, USA., Piccoli L; Humabs BioMed, Bellinzona, Switzerland., Case JB; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA., Beltramello M; Humabs BioMed, Bellinzona, Switzerland., Guarino B; Humabs BioMed, Bellinzona, Switzerland., Dang H; Vir Biotechnology, San Francisco, CA, USA., de Melo GD; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Pinto D; Humabs BioMed, Bellinzona, Switzerland., Sprouse K; Department of Biochemistry, University of Washington, Seattle, WA, USA., Scheaffer SM; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Bassi J; Humabs BioMed, Bellinzona, Switzerland., Silacci-Fregni C; Humabs BioMed, Bellinzona, Switzerland., Muoio F; Humabs BioMed, Bellinzona, Switzerland., Dini M; Humabs BioMed, Bellinzona, Switzerland., Vincenzetti L; Humabs BioMed, Bellinzona, Switzerland., Acosta R; Vir Biotechnology, San Francisco, CA, USA., Johnson D; Vir Biotechnology, San Francisco, CA, USA., Subramanian S; Vir Biotechnology, San Francisco, CA, USA., Saliba C; Humabs BioMed, Bellinzona, Switzerland., Giurdanella M; Humabs BioMed, Bellinzona, Switzerland., Lombardo G; Humabs BioMed, Bellinzona, Switzerland., Leoni G; Humabs BioMed, Bellinzona, Switzerland., Culap K; Humabs BioMed, Bellinzona, Switzerland., McAlister C; Vir Biotechnology, San Francisco, CA, USA., Rajesh A; Vir Biotechnology, San Francisco, CA, USA., Dellota E Jr; Vir Biotechnology, San Francisco, CA, USA., Zhou J; Vir Biotechnology, San Francisco, CA, USA., Farhat N; Vir Biotechnology, San Francisco, CA, USA., Bohan D; Vir Biotechnology, San Francisco, CA, USA., Noack J; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Lempp FA; Vir Biotechnology, San Francisco, CA, USA., Quispe J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Kergoat L; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Larrous F; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Cameroni E; Humabs BioMed, Bellinzona, Switzerland., Whitener B; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Cippà P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland., Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Franzetti-Pellanda A; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Biggiogero M; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Zappi S; Division of Nephrology, Cantonal Hospital Aarau, Aarau, Switzerland., Bernasconi L; Institute of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland., Kim MJ; Division of Nephrology, Cantonal Hospital Aarau, Aarau, Switzerland., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Schnell G; Vir Biotechnology, San Francisco, CA, USA., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., Benigni F; Humabs BioMed, Bellinzona, Switzerland., Franko N; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Logue JK; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Yoshiyama C; Department of Biochemistry, University of Washington, Seattle, WA, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, WA, USA., Chu H; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Bourhy H; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Schmid MA; Humabs BioMed, Bellinzona, Switzerland., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Snell G; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs BioMed, Bellinzona, Switzerland., Diamond MS; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu., Corti D; Humabs BioMed, Bellinzona, Switzerland. dcorti@vir.bio., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA. dveesler@uw.edu.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA. dveesler@uw.edu.
Publikováno v:
Nature [Nature] 2023 Sep; Vol. 621 (7979), pp. 592-601. Date of Electronic Publication: 2023 Aug 30.
Autor:
Momont C; Vir Biotechnology, San Francisco, CA, USA., Dang HV; Vir Biotechnology, San Francisco, CA, USA., Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Hauser K; Vir Biotechnology, San Francisco, CA, USA., Wang C; Vir Biotechnology, San Francisco, CA, USA., di Iulio J; Vir Biotechnology, San Francisco, CA, USA., Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Branch K; Vir Biotechnology, San Francisco, CA, USA., Donermeyer D; Vir Biotechnology, San Francisco, CA, USA., Vyas S; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Ferri E; Vir Biotechnology, San Francisco, CA, USA., Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Powell AE; Vir Biotechnology, San Francisco, CA, USA., Spreafico R; Vir Biotechnology, San Francisco, CA, USA., Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK., Belnap DM; School of Biological Sciences and Department of Biochemistry, University of Utah, Salt Lake City, Utah, USA., Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Timothy Schaiff W; Vir Biotechnology, San Francisco, CA, USA., Miller JL; Vir Biotechnology, San Francisco, CA, USA., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Telenti A; Vir Biotechnology, San Francisco, CA, USA., Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Snell G; Vir Biotechnology, San Francisco, CA, USA., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Publikováno v:
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada [Microsc Microanal] 2023 Jul 22; Vol. 29 (29 Suppl 1), pp. 927.
Autor:
Momont C; Vir Biotechnology, San Francisco, CA, USA., Dang HV; Vir Biotechnology, San Francisco, CA, USA., Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Hauser K; Vir Biotechnology, San Francisco, CA, USA., Wang C; Vir Biotechnology, St. Louis, MO, USA., di Iulio J; Vir Biotechnology, San Francisco, CA, USA., Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Branch K; Vir Biotechnology, San Francisco, CA, USA., Donermeyer D; Vir Biotechnology, St. Louis, MO, USA., Vyas S; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Ferri E; Vir Biotechnology, San Francisco, CA, USA., Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Powell AE; Vir Biotechnology, San Francisco, CA, USA., Spreafico R; Vir Biotechnology, San Francisco, CA, USA., Yim SS; Vir Biotechnology, San Francisco, CA, USA., Balce DR; Vir Biotechnology, San Francisco, CA, USA., Bartha I; Vir Biotechnology, San Francisco, CA, USA., Meury M; Vir Biotechnology, San Francisco, CA, USA., Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK., Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA., Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Schaiff WT; Vir Biotechnology, St. Louis, MO, USA., Miller JL; Vir Biotechnology, San Francisco, CA, USA., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Telenti A; Vir Biotechnology, San Francisco, CA, USA., Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Snell G; Vir Biotechnology, San Francisco, CA, USA. gsnell@vir.bio., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. mpizzuto@vir.bio.
Publikováno v:
Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. E50.
Autor:
von Delft A; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Annette.vondelft@cmd.ox.ac.uk.; Oxford Biomedical Research Centre, National Institute for Health Research, University of Oxford, Oxford, UK. Annette.vondelft@cmd.ox.ac.uk., Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Kwong AD; Pardes Biosciences, Carlsbad, CA, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Saikatendu KS; Drug Discovery Sciences, Takeda California, Inc., San Diego, CA, USA., Schmitz U; Gilead Sciences, Inc., Foster City, CA, USA., Tallarico JA; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Lee AA; PostEra, Inc., Cambridge, MA, USA. alpha.lee@postera.ai.; Cavendish Laboratory, University of Cambridge, Cambridge, UK. alpha.lee@postera.ai.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2023 Jul; Vol. 22 (7), pp. 585-603. Date of Electronic Publication: 2023 May 12.
Autor:
Momont C; Vir Biotechnology, San Francisco, CA, USA., Dang HV; Vir Biotechnology, San Francisco, CA, USA., Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Hauser K; Vir Biotechnology, San Francisco, CA, USA., Wang C; Vir Biotechnology, St. Louis, MO, USA., di Iulio J; Vir Biotechnology, San Francisco, CA, USA., Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Branch K; Vir Biotechnology, San Francisco, CA, USA., Donermeyer D; Vir Biotechnology, St. Louis, MO, USA., Vyas S; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Ferri E; Vir Biotechnology, San Francisco, CA, USA., Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Powell AE; Vir Biotechnology, San Francisco, CA, USA., Spreafico R; Vir Biotechnology, San Francisco, CA, USA., Yim SS; Vir Biotechnology, San Francisco, CA, USA., Balce DR; Vir Biotechnology, San Francisco, CA, USA., Bartha I; Vir Biotechnology, San Francisco, CA, USA., Meury M; Vir Biotechnology, San Francisco, CA, USA., Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK., Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA., Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Schaiff WT; Vir Biotechnology, St. Louis, MO, USA., Miller JL; Vir Biotechnology, San Francisco, CA, USA., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Telenti A; Vir Biotechnology, San Francisco, CA, USA., Virgin HW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Snell G; Vir Biotechnology, San Francisco, CA, USA. gsnell@vir.bio., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. mpizzuto@vir.bio.
Publikováno v:
Nature [Nature] 2023 Jun; Vol. 618 (7965), pp. 590-597. Date of Electronic Publication: 2023 May 31.